Ryan & Maniskas, LLP Announces Investigation of Clarient, Inc.
23 Ottobre 2010 - 4:00AM
Business Wire
Ryan & Maniskas, LLP (www.rmclasslaw.com/cases/clrt) is
investigating potential claims against the board of directors of
Clarient, Inc. ("Clarient" or the "Company") (NASDAQ: CLRT)
concerning possible breaches of fiduciary duty and other violations
of law related to the Company’s efforts to sell Clarient to GE
Healthcare, a unit of General Electric Company in a transaction
with a value of approximately $580 million.
Our investigation concerns possible breaches of fiduciary duty
and other violations of law related to approval of the transaction
by Company’s board of directors; in particular, whether the Company
undertook a fair process to obtain fair consideration for all
shareholders of Clarient. For more information regarding our
investigation, please contact Ryan & Maniskas, LLP (Richard A.
Maniskas, Esquire) toll-free at (877) 316-3218 or by email at
rmaniskas@rmclasslaw.com or visit:
www.rmclasslaw.com/cases/clrt.
Under the terms of the agreement, Clarient shareholders will
receive will receive $5.00 in cash for each Clarient common share
and $20.00 in cash for each preferred share.
If you own shares of Clarient and would like to learn more about
these claims or if you wish to discuss these matters and have any
questions concerning this announcement or your rights, contact
Richard A. Maniskas, Esquire toll-free at (877) 316-3218 or to sign
up online, visit: www.rmclasslaw.com/cases/clrt. You may also email
Mr. Maniskas at rmaniskas@rmclasslaw.com. For more information
about class action cases in general, please visit our website:
www.rmclasslaw.com.
Ryan & Maniskas, LLP is a national shareholder litigation
firm. Ryan and Maniskas, LLP is devoted to protecting the interests
of individual and institutional investors in shareholder actions in
state and federal courts nationwide.
Grafico Azioni Clarient, Inc. (MM) (NASDAQ:CLRT)
Storico
Da Mag 2024 a Giu 2024
Grafico Azioni Clarient, Inc. (MM) (NASDAQ:CLRT)
Storico
Da Giu 2023 a Giu 2024
Notizie in Tempo Reale relative a Clarient, Inc. (MM) (NASDAQ): 0 articoli recenti
Più Ryan & Maniskas, LLP Articoli Notizie